Samsung Biologics unlocks additional capacity for production at newest Plant 4

Samsung Biologics, South Korea-based contract development and manufacturing organization (CDMO), has announced that its ...

October 12, 2022 | Wednesday | News
Fujifilm to establish first Bio-CDMO site in Japan

Fujifilm Corporation has announced that it will establish the company’s first Japanese Bio-CDMO (contract developm...

October 10, 2022 | Monday | News
Cytiva strengthens cell line development with CEVEC acquisition

Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cel...

October 6, 2022 | Thursday | News
Samsung Biologics to launch new platforms for antibody development process

South Korea-based Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is laun...

September 30, 2022 | Friday | News
Biosyngen boosts cell therapy GMP capabilities in Singapore

Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...

September 28, 2022 | Wednesday | News
WuXi STA opens first high potency oral drug product manufacturing facility

WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...

September 28, 2022 | Wednesday | News
Bora Pharma partners with TaiRx to manufacture breakthrough anticancer drug in Taiwan

Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...

September 26, 2022 | Monday | News
Hong Kong-based startup Great Bay Bio secures $15M funding

Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...

September 15, 2022 | Thursday | News
Catalent invests $2.2M for Singapore clinical supply facility expansion

Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...

September 7, 2022 | Wednesday | News
Dr Glenn Haifer and Ampersand Capital Partners acquire Australian biologics CDMO Luina Bio

AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr Gle...

September 1, 2022 | Thursday | News
WuXi Biologics opens first North American biomanufacturing facility in New Jersey

China's WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has anno...

September 1, 2022 | Thursday | News
WuXi announces licensing agreement with Janssen for TESSA technology

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of China-based WuXi AppTec, has announced a licensing agre...

August 12, 2022 | Friday | News
BioDuro-Sundia and X-Chem focus on new small molecule drug discovery in China

BioDuro-Sundia, an industry-leading drug discovery, development and commercial service contract research development and...

August 8, 2022 | Monday | News
How CDMOs are Adapting to New mRNA Tech Demands

The COVID-19 pandemic highlighted the successful development and utilisation of mRNA vaccines. This has encouraged bioph...

July 30, 2022 | Saturday | Opinion
WuXi Biologics invests $1.4 B to build comprehensive CRDMO centre in Singapore

WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has announced a ...

July 19, 2022 | Tuesday | News
Samsung Biologics further invests KRW 426 B for Bio Campus 2

Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has signed a land pur...

July 18, 2022 | Monday | News
TFBS Biosciences expands state-of-the-art facility for viral vector production in Taiwan

TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacif...

July 15, 2022 | Friday | News
GenScript ProBio partners with DAAN Bio Therapeutics for novel drug discovery

GenScript ProBio, a global CDMO, and South Korea-based startup DAAN Bio Therapeutics, have entered into a strategic...

July 14, 2022 | Thursday | News